Drawing the line between life and death: the role of DNA damage in Staphylococcal infections.


   MRC DiMeN-XL Doctoral Landscape Award

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
Dr Charles Winterhalter, Prof S J Foster, Dr Katarzyna Mickiewicz  No more applications being accepted  Competition Funded PhD Project (Students Worldwide)

About the Project

By 2050, bacterial pathogens will be the biggest threat to human health due to the rise in antimicrobial resistance. For example, Staphylococcus aureus is the leading Gram-positive bacterium causing death from bacterial infections worldwide and contributed to killing approximately one million people in 2019. Unfortunately, only few antibiotics remain efficient to clear bacterial infections and bacteria are becoming increasingly resistant even to our last-resort treatment options. To clear infections, exposure to antibiotics and the immune response are known to increase production of toxic molecules such as reactive oxygen species, which lead to DNA damage and impaired bacterial proliferation. However, despite determining life or death of the pathogen, the molecular processes underpinning bacterial DNA damage repair during infection are poorly understood.

To decipher the complex mechanisms underlying DNA damage repair processes, we recently established an innovative approach using the CrispR/Cas9 system to introduce a single specific DNA break at a defined position on the bacterial chromosome. We used this method to identify several novel genes involved in single- and/or double-strand DNA break repair and surprisingly, we discovered that inactivation of some of these factors could kill clinical, antibiotic-resistant S. aureus strains upon induction of targeted DNA damage. Because the activity of these novel proteins is unknown, we must investigate their functions to understand their role in DNA damage repair and their potential to attenuate infection.

This interdisciplinary project aims to identify the functions of novel DNA repair proteins with potential to attenuate antimicrobial resistance using laboratory and clinical strains of the human pathogen S. aureus. Shared work experience between the labs of Supervisors 1 and 3 (Newcastle) and Supervisor 2 (Sheffield) will enable discovery of collaborative research in a supportive, inclusive and healthy environment. Our team will train the student in genetics and biochemistry using a range of live cell and in vitro techniques, with the rare opportunity to also become proficient in infection science using immune cells such as macrophages and neutrophils. Together, this comprehensive training will enable the student to develop a highly sought-after and unique skillset in fundamental science with direct experience in infection. Importantly, exploring the roles of novel enzymes sensitising antibiotic-resistant S. aureus to DNA damage could create a paradigm shift in the fight against antimicrobial resistance.

Supervisor 1:

https://www.ncl.ac.uk/medical-sciences/people/profile/charleswinterhalter.html

@Ch_Winterhalter (Twitter/X)

Supervisor 2:

https://thefosterlab.sites.sheffield.ac.uk/

@foster_lab (Twitter/X)

Supervisor 3:

https://www.ncl.ac.uk/medical-sciences/people/profile/katarzynamickiewicz.html

@MicKasia (Twitter/X)

This project is part of the Discovery Medicine North Doctoral Training Partnership (DiMeN DTP), a diverse community of PhD students across the North of England researching the major health problems facing the world today. Our partner institutions (Universities of Leeds, Liverpool, Newcastle, York and Sheffield) are internationally recognised as centres of research excellence and can offer you access to state-of the-art facilities to deliver high impact research.

We are very proud of our student-centred ethos and committed to supporting you throughout your PhD. As part of the DTP, we offer bespoke training in key skills sought after in early career researchers, as well as opportunities to broaden your career horizons in a range of non-academic sectors.

Being funded by the MRC means you can access additional funding for research placements, international training opportunities or internships in science policy, science communication and beyond. See how our current DiMeN students have benefited from this funding here: https://www.dimen.org.uk/blog

Further information on the programme and how to apply can be found on our website:

https://www.dimen.org.uk/how-to-apply

Biological Sciences (4) Medicine (26)

Funding Notes

Studentships are fully funded by the Medical Research Council (MRC) for 4yrs. Funding will cover tuition fees, stipend (£18,622 p.a. for 2023/24)) and project costs. We also aim to support the most outstanding applicants from outside the UK and are able to offer a limited number of full studentships to international applicants. Please read additional guidance here: https://www.dimen.org.uk/eligibility-criteria
Studentships commence: 1st October 2024
Good luck!

References

Please note that Supervisor 1 is currently preparing a manuscript to publish the targeted DNA damage method and initial findings leading up to this project. Publications (1) and (2) were critical to Supervisor 1’s endeavour to engineer this targeted DNA damage approach and establish their lab, publications (3) and (4) demonstrate Supervisor 2’s expertise in S. aureus physiology and publication (5) shows Supervisor’s 3 experience in infection science.
(1) The DNA replication initiation protein DnaD recognises a specific strand of the Bacillus subtilis chromosome origin, Nucleic Acids Research (2023) 51:4322. (PhD students: third and fifth author)
https://doi.org/10.1093/nar/gkad277
(2) SirA inhibits the essential DnaA:DnaD interaction to block helicase recruitment during Bacillus subtilis sporulation, Nucleic Acids Research (2023) 51:4302. (PhD students: second and fifth author)
https://doi.org/10.1093/nar/gkac1060
(3) The architecture of the Gram-positive bacterial cell wall, Nature (2020) 582:294. (PhD student first author)
https://doi.org/10.1038/s41586-020-2236-6
(4) Evolving MRSA: High-level β-lactam resistance in Staphylococcus aureus is associated with RNA Polymerase alterations and fine tuning of gene expression, PLoS Pathogens (2020) 16:e1008672. (PhD student first author)
https://doi.org/10.1371/journal.ppat.1008672
(5) Lysozyme Counteracts β-Lactam Antibiotics by Promoting the Emergence of L-Form Bacteria, Cell (2018) 172(5):1038-1049.e10.
https://doi.org/10.1016/j.cell.2018.01.021
Search Suggestions

Search suggestions

Based on your current searches we recommend the following search filters.

Search Suggestions

PhD suggestions

Based on your current search criteria we thought you might be interested in these.